Table 7.
Stability of cefazolin under different storage conditions.
| Human samples |
Rat samples |
|||
|---|---|---|---|---|
| mean accuracy [%] | CV [%] (n=3) | mean accuracy [%] | CV [%] (n=3) | |
|
| ||||
| adipose tissue homogenate stability | ||||
| • bench-top [20°C, 6 h] | ||||
| LQC | 98.1 | 9.6 | 100.9 | 1.8 |
| ULOQ | 96.6 | 1.0 | 97.8 | 3.0 |
| • freeze-thaw [−80°C, 3 cycles] | ||||
| LQC | 102.0 | 0.4 | - | - |
| ULOQ | 90.0 | 3.4 | - | - |
| • long-term [−80°C, 8 weeks] | ||||
| LQC | 92.3 | 5.5 | - | - |
| ULOQ | 97.7 | 0.9 | - | - |
| in-filtrate stability | ||||
| • short-term [10°C, 24 h] | ||||
| LQC | 98.8 | 2.6 | 102.9 | 5.2 |
| ULOQ | 99.3 | 3.5 | 97.6 | 1.4 |
| • long-term [−20°C, 12 days] | ||||
| LQC | - | - | 112.4 | 2.1 |
| ULOQ | - | - | 106.0 | 2.2 |
| aqueous solutions stability | ||||
| • stock solution [−20°C, 11 weeks] | ||||
| LQC | - | - | 100.3 | 4.5 |
| ULOQ | - | - | 100.4 | 4.5 |
| • working solutions [−20°C, 4 weeks] | ||||
| LQC | - | - | 102.7 | 2.0 |
| ULOQ | - | - | 95.9 | 4.0 |
LQC = 0.1 μg/mL, ULOQ = 50 μg/mL of cefazolin in adipose tissue homogenate.